Showing results (51-60 of 73) with videos related to

Sort By:
Pageof 8
Breast Cancer Research and Treatment|October 12, 1999
Breast cancer and timing of surgery during menstrual cycle: a 5-year analysis of 248 premenopausal womenM Milella, C Nisticò, V Ferraresi, et al.
British Journal of Cancer|April 20, 2001
5-fluorouracil modulated by leucovorin, methotrexate and mitomycin: highly effective, low-cost chemotherapy for advanced colorectal cancerA Sobrero, A Guglielmi, M Cirillo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 5, 2002
Multicenter phase II-III study of oxaliplatin plus cyclophosphamide vs. cisplatin plus cyclophosphamide in chemonaive advanced ovarian cancer patientsJ L Misset, P Vennin, P H Chollet, et al.
Journal of Cancer Research and Clinical Oncology|June 6, 2013
Circulating tumor cells in metastatic colorectal cancer: do we need an alternative cutoff?P Gazzaniga, C Raimondi, A Gradilone, et al.
Breast Cancer Research : BCR|November 1, 2000
BRCA1 and BRCA2 mutations in central and southern Italian patientsL Ottini, C D'Amico, C Noviello, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 9, 2006
BRCA1 and BRCA2 genetic testing in Italian breast and/or ovarian cancer families: mutation spectrum and prevalence and analysis of mutation prediction modelsC Capalbo, E Ricevuto, A Vestri, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|June 28, 2021
Intensified Total Neoadjuvant Therapy in Patients With Locally Advanced Rectal Cancer: A Phase II TrialF De Felice, G D'Ambrosio, F Iafrate, et al.
Lung Cancer (Amsterdam, Netherlands)|October 3, 2006
Induction cisplatin-gemcitabine-paclitaxel plus concurrent radiotherapy and gemcitabine in the multimodality treatment of unresectable stage IIIB non-small cell lung cancerL Trodella, F De Marinis, R M D'Angelillo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 26, 2015
Early tumor shrinkage and depth of response predict long-term outcome in metastatic colorectal cancer patients treated with first-line chemotherapy plus bevacizumab: results from phase III TRIBE trial by the Gruppo Oncologico del Nord OvestC Cremolini, F Loupakis, C Antoniotti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 6, 2001
Schedule specific biochemical modulation of 5-fluorouracil in advanced colorectal cancer: a randomized study. GISCAD, IOR and collaborating centersA Sobrero, A Zaniboni, G L Frassineti, et al.
Pageof 8